| 引用本文： |
-
姜璎慈,田 吉,张 芬,等.精神分裂症患者使用抗精神病长效治疗药物意愿调查分析[J].同济大学学报（医学版）,2022,43(1):120-124. [点击复制]
- JIANG Yingci,TIAN Ji,ZHANG Fen,et al.Attitude towards long-acting injection and its influential factors among family caregivers of schizophrenic patients[J].同济大学学报（医学版）,2022,43(1):120-124. [点击复制]
|
|
| 摘要: |
| 目的 了解辖区精神分裂症家属对长效治疗药物的知晓程度和使用态度，为制定抗精神病长效药物的推广政策提供参考意见。方法 使用自行编制《精神分裂症患者家属对长效治疗药物的使用意愿情况》调查表，通过面对面调查的方式开展调查。应用SPSS 22.0软件进行描述性分析、单因素χ2检验、多因素非条件Logistic回归分析。结果 63.8%（785/1 231）的家属听过长效治疗药物，28.8%（354/1 231）的家属了解目前的长效治疗药物种类。愿意尝试使用长效药物的占7.3%（90/1 231），不会尝试使用的占42.0%（517/1 231），暂时不考虑的占50.7%（624/1 231）。其中患者不同意的比例占56.7%，家属对医生的建议最为看重。多因素分析结果显示，男性、风险等级为红色的患者、就诊时有人陪诊的、他人给药的、住院次数越多越愿意接受长效药物。结论 抗精神病长效治疗药物的宣传首先应加强医疗机构医生的对外普及，重点提高高风险患者及家属对长效药物的接受度，提高病患规律服药的依从性，促进病患的有效康复，维护社会稳定。 |
| 关键词: 精神分裂症 家属 抗精神病长效药物 使用意愿 |
| DOI：10.12289/j.issn.1008-0392.21216 |
| 投稿时间：2021-05-21 |
| 基金项目:上海市卫生健康委员会政策研究课题（2022）；上海市徐汇区精神卫生中心项目(徐精中（院）202101)；上海市徐汇区智慧医疗专项研究项目（XHZH202115） |
|
| Attitude towards long-acting injection and its influential factors among family caregivers of schizophrenic patients |
| JIANG Yingci,TIAN Ji,ZHANG Fen,ZHOU Qing,ZHANG Weibo,NI Hua |
| (Department of Disease Prevention and Control, Shanghai Xuhui Mental Health Center, Shanghai 200232, China;Department of Disease Prevention and Control, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200230, China) |
| Abstract: |
| Objective To investigate the awareness and attitude towards using long-term acting injectable(LAI) anti-psychotics among family caregivers of schizophrenic patients. Methods A face to face questionnaire survey was conducted from November to December 2020 among 1 231 caregivers of patients with schizophrenia in Shanghai Xuhui Districts. The data were analyzed by SPSS 22.0 descriptive epidemiological analysis, Chi-square test and t-test. Results The survey showed that 63.8% of the caregivers had heard of LAI, 28.8% of them were aware of the current types of LAI; only 7.3% were willing to get LAI, 42.0% were unwilling to attempt LAI, and the rest 50.7% of caregivers were hesitate whether to get LAI or not. Level of acceptance of caregivers was affected by multiple factors including gender, risk degree, accompanied visits, medication helped by others, and frequency of hospitalization. Conclusion Mental health professionals should take the initiative to strengthen the awareness and acceptance of LAI for high-risk schizophrenic patients and their family caregivers, to increase the compliance of regularly drug intaking, and promote a more effective treatment. |
| Key words: schizophrenia family caregivers long-term acting injectable acceptance |
